Lanean...
The FDA Oncology Center of Excellence and precision medicine
In January 2017, the U.S. Food and Drug Administration (FDA) formally established the Oncology Center of Excellence (OCE) to streamline the development of cancer therapies by uniting experts from FDA product centers to conduct expedited review of drugs, biologics, and devices. In May 2017, the FDA a...
Gorde:
| Argitaratua izan da: | Exp Biol Med (Maywood) |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAGE Publications
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5813869/ https://ncbi.nlm.nih.gov/pubmed/29105511 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370217740861 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|